Patent Document ID: 10041959
Application ID: 15391755
Patent Flag: 1

Claim One:
1. A process for detecting an autoantibody to glial fibrillary acid protein (GFAP) or a breakdown product thereof comprising: measuring an autoantibody to GFAP or an autoantibody to a GFAP breakdown product in a sample obtained from a subject presenting with clinical symptoms of a traumatic brain injury by contacting the sample with GFAP or a GFAP breakdown product and detecting binding between the autoantibody to GFAP and GFAP or between the autoantibody to the GFAP breakdown product and the GFAP breakdown product, wherein the GFAP is set forth in SEQ ID NO: 114, and wherein the GFAP breakdown product is within 10 amino acids of the cleavage site at amino acid position 59 or 383 set forth in SEQ ID NO: 114.